Cancer Treatments
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
43
NCT07151040
Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
Phase: Phase 1/2
Role: Lead Sponsor
Start: Aug 22, 2025
Completion: Dec 31, 2026
Loading map...